BIODEXA PHARMACEUTICALS-ADR (BDRX) Stock Balance Sheet
NASDAQ:BDRX - Nasdaq - US59564R8079 - ADR - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.05M | 5.97M | 2.84M | 10.06M | 7.55M | |||
| Receivables | 2.47M | 704.00K | 1.48M | 1.10M | 1.47M | |||
| Inventories | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Current Assets | N/A | 355.00K | 376.00K | 607.00K | 258.00K | |||
| Total Current Assets | 7.52M | 7.03M | 4.69M | 11.76M | 9.28M | |||
| Non-Current Assets | ||||||||
| PPE Net | 436.00K | 571.00K | 831.00K | 1.15M | 542.00K | |||
| Goodwill | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Intangibles | 6.01M | 2.94M | 6.00K | 0.00 | 0.00 | |||
| Total Non-Current Assets | 6.44M | 3.51M | 837.00K | 1.15M | 542.00K | |||
| TOTAL ASSETS | 13.97M | 10.54M | 5.53M | 12.91M | 9.82M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 174.00K | 169.00K | 161.00K | 146.00K | 200.00K | |||
| Accrued Expenses | N/A | 857.00K | 817.00K | 546.00K | 768.00K | |||
| Accounts Payable | 1.69M | 1.55M | 339.00K | 485.00K | 337.00K | |||
| Other Current Liabilities | 1.62M | 4.23M | 583.00K | 664.00K | 1.68M | |||
| Total Current Liabilities | 3.48M | 5.57M | 1.90M | 1.84M | 2.99M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 208.00K | 295.00K | 463.00K | 620.00K | 60.00K | |||
| Other Non-Current Liabilities | 1.55M | N/A | 0.00 | 0.00 | 50.00K | |||
| Total Non-Current Liabilities | 1.76M | 295.00K | 463.00K | 620.00K | 110.00K | |||
| TOTAL LIABILITIES | 5.24M | 5.86M | 2.36M | 2.46M | 3.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -91.20M | -88.31M | -81.61M | -74.08M | -68.71M | |||
| Additional Paid In Capital | 91.24M | 86.73M | 83.67M | 83.43M | 74.36M | |||
| Common Shares | 8.69M | 6.25M | 1.11M | 1.10M | 1.06M | |||
| Other Shareholders' Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 29.56K | 9.70K | 44.16 | 0.50 | 8.03 | |||
| Tangible Book Value per Share | 0.02 | 0.04 | 14.56 | 4.25K | 170.42 | |||
| Total Shareholders' Equity | 8.73M | 4.68M | 3.16M | 10.45M | 6.72M | |||
| TOTAL LIABILITIES AND EQUITY | 13.97M | 10.54M | 5.53M | 12.91M | 9.82M | |||
| Statistics | ||||||||
| Debt/Equity | 0.02 | 0.06 | 0.15 | 0.06 | 0.01 | |||
| Current Ratio | 2.16 | 1.26 | 2.47 | 6.39 | 3.10 | |||
| Return On Assets (ROA) | -48.82% | -67.15% | -138.57% | -42.28% | -226.03% | |||
| Return On Equity (ROE) | -78.14% | -151.33% | -242.13% | -52.24% | -330.29% | |||
All data in GBP , ROIC based on taxRate of 0.21